TY - JOUR
T1 - Nanocarrier Vaccines for SARS-CoV-2
AU - Machhi, Jatin
AU - Shahjin, Farah
AU - Das, Srijanee
AU - Patel, Milankumar
AU - Abdelmoaty, Mai Mohamed
AU - Cohen, Jacob D.
AU - Singh, Preet Amol
AU - Baldi, Ashish
AU - Bajwa, Neha
AU - Kumar, Raj
AU - Vora, Lalit K.
AU - Patel, Tapan A.
AU - Oleynikov, Maxim D.
AU - Soni, Dhruvkumar
AU - Yeapuri, Pravin
AU - Mukadam, Insiya
AU - Chakraborty, Rajashree
AU - Saksena, Caroline G.
AU - Herskovitz, Jonathan
AU - Hasan, Mahmudul
AU - Oupicky, David
AU - Das, Suvarthi
AU - Donnelly, Ryan F.
AU - Hettie, Kenneth S.
AU - Chang, Linda
AU - Gendelman, Howard E.
AU - Kevadiya, Bhavesh D.
PY - 2021/1/9
Y1 - 2021/1/9
N2 - The SARS-CoV-2 global pandemic has seen rapid spread, disease mobidities and death associated with substantive social, economic and societal impact. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative therapies exist. Vaccines remain the best hope for disease control and elimination and the principal global effort with success now being realized. Herein, we summarize those developments with a focus on the role played by nanocarrier delivery.
AB - The SARS-CoV-2 global pandemic has seen rapid spread, disease mobidities and death associated with substantive social, economic and societal impact. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative therapies exist. Vaccines remain the best hope for disease control and elimination and the principal global effort with success now being realized. Herein, we summarize those developments with a focus on the role played by nanocarrier delivery.
U2 - 10.1016/j.addr.2021.01.002
DO - 10.1016/j.addr.2021.01.002
M3 - Review article
SN - 0169-409X
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
ER -